Back to top
more

Tenet Healthcare (THC)

(Delayed Data from NYSE)

$151.63 USD

151.63
1,459,243

+1.89 (1.26%)

Updated Jul 26, 2024 04:00 PM ET

After-Market: $151.64 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tenet Healthcare (THC) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Tenet Healthcare (THC) closed the most recent trading day at $74.23, moving +0.49% from the previous trading session.

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Universal Health (UHS) Gains From Solid Segmental Performance

by Zacks Equity Research

Universal Health (UHS) gains from the uptrend in revenue growth, which in turn, is derived from expanding patient volumes. A credible financial position drives its expansion endeavors.

Encompass Health's (EHC) Q2 Earnings Beat, '23 EPS View Raised

by Zacks Equity Research

Encompass Health's (EHC) Q2 results reflect a growing patient base and improved net patient revenue per discharge. Management anticipates 2023 adjusted EPS within $3.31-$3.53, up from the earlier view of $2.94-$3.23.

Tenet Healthcare (THC) Q2 Earnings Beat on Solid Hospital Unit

by Zacks Equity Research

Tenet Healthcare's (THC) Q2 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.18-$6.03 for this year.

Compared to Estimates, Tenet (THC) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Tenet Healthcare (THC) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Tenet (THC) delivered earnings and revenue surprises of 14.29% and 3.70%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Acadia Healthcare (ACHC) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 10.84% and 3.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Can Conifer Weakness Affect Tenet Healthcare's (THC) Q2 Earnings?

by Zacks Equity Research

Tenet Healthcare's (THC) second-quarter results are likely to reflect higher Ambulatory Care operating revenues and supply costs.

Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Tenet Healthcare (THC) closed at $77.20 in the latest trading session, marking a +0.4% move from the prior day.

Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Tenet Healthcare (THC) closed at $80.37 in the latest trading session, marking a -0.1% move from the prior day.

Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for ISCV

All You Need to Know About Tenet (THC) Rating Upgrade to Strong Buy

by Zacks Equity Research

Tenet (THC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Industry Outlook Highlights HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems

by Zacks Equity Research

HCA Healthcare, Universal Health, Tenet Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.

Kaibalya Pravo Dey headshot

4 Hospital Stocks in Focus Amid Improving Industry Trends

by Kaibalya Pravo Dey

Delayed elective procedures are boosting patient volumes for the Zacks Medical-Hospital industry players. HCA Healthcare (HCA), Universal Health (UHS), Tenet Healthcare (THC) and Community Health (CYH) are poised to gain from improving occupancy rates.

Universal Health (UHS) Gains 3.7% as Pent-Up Surgeries Rise

by Zacks Equity Research

The pent-up demand for elective surgeries is expected to improve Universal Health's (UHS) patient admissions and patient days.

Universal Health Services (UHS) Surges 3.7%: Is This an Indication of Further Gains?

by Zacks Equity Research

Universal Health Services (UHS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Community Health Systems (CYH) Down 16% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tenet Healthcare (THC) Gains 42.1% YTD: More Room to Run?

by Zacks Equity Research

Tenet Healthcare's (THC) aim to boost USPI's network through continuous buyouts is positioning the company well for growth.

Tenet (THC) Down 3.9% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for ISCV

Here's Why You Should Hold Molina (MOH) in Your Portfolio

by Zacks Equity Research

Molina's (MOH) inorganic growth activities, financial flexibility and well-performing Medicaid and Medicare segments poise it for growth.

Tenet (THC) Is Attractively Priced Despite Fast-paced Momentum

by Zacks Equity Research

Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Community Health (CYH) Stock Down 41.9% Since Q1 Earnings Release

by Zacks Equity Research

Community Health's (CYH) Q1 results reflect deteriorating metrics like patient days, length of stay and occupancy rates. However, rising admissions partially offset the negatives.